These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38967099)

  • 21. Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.
    Kataoka A; Mizumoto C; Kanda J; Iwasaki M; Sakurada M; Oka T; Fujimoto M; Yamamoto Y; Yamashita K; Nannya Y; Ogawa S; Takaori-Kondo A
    Int J Hematol; 2023 Jun; 117(6):919-924. PubMed ID: 36641501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
    Huang H; Zhang W; Cai W; Liu J; Wang H; Qin T; Xu Z; Li B; Qu S; Pan L; Huang G; Gale RP; Xiao Z
    Exp Hematol Oncol; 2021 Mar; 10(1):23. PubMed ID: 33741056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two cases of VEXAS syndrome].
    Gunnarsson K; Vivar Pomiano N; Tesi B; Tobiasson M; Creignou M; Ungerstedt J
    Lakartidningen; 2022 Sep; 119():. PubMed ID: 36082915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
    Kunimoto H; Miura A; Maeda A; Tsuchida N; Uchiyama Y; Kunishita Y; Nakajima Y; Takase-Minegishi K; Yoshimi R; Miyazaki T; Hagihara M; Yamazaki E; Kirino Y; Matsumoto N; Nakajima H
    Int J Hematol; 2023 Oct; 118(4):494-502. PubMed ID: 37062784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.
    Padureanu V; Marinaș CM; Bobirca A; Padureanu R; Patrascu S; Dascalu AM; Bobirca F; Tribus L; Alexandru C; Serboiu C; Dumitrascu C; Musetescu A
    Cureus; 2024 Jan; 16(1):e53041. PubMed ID: 38410307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Macrocytic anemia and polychondritis: VEXAS syndrome].
    Zeisbrich M; Schindler V; Krausz M; Proietti M; Mrovecova P; Voll RE; Glaser C; Röther F; Warnatz K; Venhoff N
    Z Rheumatol; 2024 Apr; 83(3):229-233. PubMed ID: 36735069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
    Comont T; Heiblig M; Rivière E; Terriou L; Rossignol J; Bouscary D; Rieu V; Le Guenno G; Mathian A; Aouba A; Vinit J; Dion J; Kosmider O; Terrier B; Georgin-Lavialle S; Fenaux P; Mekinian A;
    Br J Haematol; 2022 Feb; 196(4):969-974. PubMed ID: 34651299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEXAS syndrome in dermatology.
    Afsahi V; Christensen RE; Alam M
    Arch Dermatol Res; 2023 Mar; 315(2):161-164. PubMed ID: 35201420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases.
    Vitale A; Caggiano V; Bimonte A; Caroni F; Tosi GM; Fabbiani A; Renieri A; Bocchia M; Frediani B; Fabiani C; Cantarini L
    Intern Emerg Med; 2023 Apr; 18(3):711-722. PubMed ID: 36662445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.
    Saad AJ; Patil MK; Cruz N; Lam CS; O'Brien C; Nambudiri VE
    Exp Dermatol; 2024 Mar; 33(3):e15050. PubMed ID: 38469984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome.
    Zakine E; Schell B; Battistella M; Vignon-Pennamen MD; Chasset F; Mahévas T; Cordoliani F; Adès L; Sébert M; Delaleu J; Jachiet M; Lepelletier C; Lemaire P; Chauvel C; Dhouaieb B; Kim R; Cassius C; Georgin-Lavialle S; Mekinian A; Bagot M; Braun T; Rousset L; Begon E; de Masson A; Fenaux P; Clappier E; Bouaziz JD
    JAMA Dermatol; 2021 Nov; 157(11):1349-1354. PubMed ID: 34495287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
    Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
    Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Challenges of Emerging Acquired Autoinflammatory Diseases, Including VEXAS Syndrome.
    Kirino Y
    Intern Med; 2024 Feb; ():. PubMed ID: 38296470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEXAS Syndrome-Review.
    Zhang Y; Dong X; Wang H
    Glob Med Genet; 2023 Sep; 10(3):133-143. PubMed ID: 37501758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of VEXAS syndrome presenting with unusual bone marrow granulomas: a diagnostic dilemma.
    Vu KT; Wolfe RM; Lambird JE; Maracaja DLV
    BMC Rheumatol; 2023 Jul; 7(1):18. PubMed ID: 37430338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review.
    Kouranloo K; Ashley A; Zhao SS; Dey M
    Rheumatol Int; 2023 Jun; 43(6):1023-1032. PubMed ID: 36617363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia.
    Austestad J; Madland TM; Sandnes M; Haslerud TM; Benneche A; Reikvam H
    Case Rep Hematol; 2023; 2023():6551544. PubMed ID: 36879894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediastinal lymphadenopathy due to VEXAS syndrome.
    Burgei J; Alsheimer KM; Lantry J; Hehn B
    BMJ Case Rep; 2024 Aug; 17(8):. PubMed ID: 39122375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
    Borie R; Debray MP; Guedon AF; Mekinian A; Terriou L; Lacombe V; Lazaro E; Meyer A; Mathian A; Ardois S; Vial G; Moulinet T; Terrier B; Jamilloux Y; Heiblig M; Bouaziz JD; Zakine E; Outh R; Groslerons S; Bigot A; Flamarion E; Kostine M; Henneton P; Humbert S; Constantin A; Samson M; Bertrand NM; Biscay P; Dieval C; Lobbes H; Jeannel J; Servettaz A; Adelaide L; Graveleau J; de Sainte-Marie B; Galland J; Guillotin V; Duroyon E; Templé M; Bourguiba R; Georgin Lavialle S; Kosmider O; Audemard-Verger A;
    Chest; 2023 Mar; 163(3):575-585. PubMed ID: 36272567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS.
    Wu Z; Gao S; Gao Q; Patel BA; Groarke EM; Feng X; Manley AL; Li H; Ospina Cardona D; Kajigaya S; Alemu L; Quinones Raffo D; Ombrello AK; Ferrada MA; Grayson PC; Calvo KR; Kastner DL; Beck DB; Young NS
    Cell Rep Med; 2023 Aug; 4(8):101160. PubMed ID: 37586319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.